Careers in the Biopharmaceutical Industry and assessing companies and products

Monday, October 2, 2017 - 2:00pm - 3:00pm

Location: Petit Institute 1128 Suddath Room

Join us and Dr. Kumar for an open conversation about her current role in assessing and valuing pharmaceutical companies and products, as well as for advice in pursuing careers in small biotech companies and large pharmaceutical industries. Dr. Kumar has experience advancing several small molecules and proteins into initial clinical development and continuing to support them through later stages of development and eventual regulatory approval. 

Dr. Anjali Kumar has had nearly 20 years of experience with increasing responsibility in the biopharmaceutical industry, and is currently the Due Diligence Lead, Corporate Development for Shire Pharmaceuticals. She previously served as the vice president, nonclinical R&D and scientific affairs at Flexion Therapeutics, Inc. She has experience advancing several small molecules and proteins into initial clinical development and continuing to support them through later stages of development and eventual regulatory approval. Kumar has worked in the area of inflammation in musculoskeletal, respiratory, and cardiovascular diseases. She received her postdoctoral training at Pharmacia and Upjohn, Inc. She holds a Ph.D. in bioengineering from Georgia Institute of Technology and a Bachelor’s degree in Chemical Engineering from the Indian Institute of Technology.

Stay Connected!

 
BBUGS is housed at the IBB

 
Events Listing

View all BBUGS Events